The use of thromboaspiration and combined treatment in patients with ischemic stroke in real-life clinical practice
T. V. Volchenkova,
S. V. Kotov,
E. V. Isakova,
M. V. Sutormin,
E. V. Patrin,
B. B. Gegenava,
M. N. Martynovich,
I. G. Rudakova,
L. V. Smetana,
V. A. Borisova,
S. V. Belkina https://doi.org/10.14412/2074-2711-2024-2-41-46
Abstract
The effectiveness of staged reperfusion therapy in real clinical practice requires clarification.
Objective: to evaluate the efficacy and safety of mechanical thromboextraction and staged reperfusion therapy with alteplase in real clinical practice.
Material and methods. The study included 106 patients who were retrospectively divided into two groups: Group I underwent staged reperfusion therapy (intravenous thrombolysis with alteplase followed by aspiration thromboextraction), Group II underwent thromboaspiration only. The clinical and functional results, incidence of hemorrhagic transformation and mortality rate were compared.
Results. The groups did not differ in terms of demographic data, cardiovascular risk factors or stroke severity. Group II patients were characterized by a longer delay in reperfusion therapy (225 minutes versus 180 minutes) and a lower score on the Alberta Stroke Programme Early CT score (ASPECTS; 8.8 points versus 9.3 points). There were no differences in National Institutes of Health Stroke Scale (NIHSS) scores at day 28, dynamics of NIHSS scores, Rankin scores at day 28, rates of hemorrhagic transformation or mortality. In both groups, the deceased patients were older; in Group I they suffered more frequently from atrial fibrillation, in Group II – from diabetes mellitus type 2. In addition, mortality in Group II was associated with a higher severity of early signs of cerebral infarction.
Conclusion. The results of the analysis of real-life clinical practice show the comparability of the efficacy and safety of staged reperfusion therapy and isolated thromboaspiration in a “natural” selection of patients.
About the Authors
T. V. Volchenkova
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
S. V. Kotov
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
E. V. Isakova
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
M. V. Sutormin
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
E. V. Patrin
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
B. B. Gegenava
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
M. N. Martynovich
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
I. G. Rudakova
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
L. V. Smetana
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
V. A. Borisova
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
S. V. Belkina
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
61/2, Shchepkina St., Moscow 129110
Competing Interests:
This article has been supported by Generium. The conflict of interest has not affected the results of the investigation. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
References
1. Skvortsova VI, Shetova IM, Kakorina EP, et al. Reduction in stroke death rates through a package of measures to improve medical care for patients with vascular diseases in the Russian Federation. Profilakticheskaya meditsina. 2018;21(1):4-10. doi: 10.17116/profmed20182114-10 (In Russ.).
2. Shamalov NA. Reperfusion therapy for ischemic stroke in the Russian Federation: problems and promises. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;6(2S):15-21. doi: 10.14412/2074-2711-2014-2S-15-21 (In Russ.).
3. Skrypnik DV, Anisimov KV, Botsina AYu, et al. Endovascular treatment results in patients with large cerebral artery occlusions in a metropolis. Moscow Stroke Registry data over 2019. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):9-17. doi: 10.14412/2074-2711-2020-5-9-17 (In Russ.).
4. Saver JL, Goyal M, Bonafe A, et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015 Jun 11;372(24):2285-95. doi: 10.1056/NEJMoa1415061. Epub 2015 Apr 17.
5. Saver JL, Jahan R, Levy EI, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012 Oct 6;380(9849):1241-9. doi: 10.1016/S0140-6736(12)61384-1. Epub 2012 Aug 26.
6. Powers WJ, Derdeyn CP, Biller J, et al; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Oct;46(10):3020-35. doi: 10.1161/STR.0000000000000074. Epub 2015 Jun 29.
7. Gusarova VD, Pantyushenko MS, Simonov VM, et al. Physico-chemical and biological properties of biosimilar and reference tissue plasminogen activator products. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreparations. Prevention, Diagnosis, Treatment. 2019;19(1):39-49. doi: 10.30895/2221-996X-2019-19-1-39-49 (In Russ.).
8. Kokorin VA, Markova OA, Gordeyev IG, et al. Recombinant tissue plazminogen activator Revelisa® in patients with myocardial infarction. Terapiya = Therapy. 2019;2:42-56. doi: 10.18565/therapy.2019.2.42-57 (In Russ.).
9. Soldatov MA, Klimov LV, Tolmachev AP, et al. Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2022;122(12-2):42-9. doi: 10.17116/jnevro202212212242 (In Russ.).
10. Analeev AI, Semitko SP. Endovascular treatment of ischemic stroke: the history of development and first experience. Consilium Medicum. 2017;19(1):36-41. doi: 10.26442/2075-1753_2017.19.1.36-41 (In Russ.).
11. Tarr R, Hsu D, Kulcsar Z, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg. 2010 Dec;2(4):341-4. doi: 10.1136/jnis.2010.002600. Erratum in: J Neurointerv Surg. 2011 Mar 1;3(1):97.
12. Nozohouri S, Sifat AE, Vaidya B, Abbruscato TJ. Novel approaches for the delivery of therapeutics in ischemic stroke. Drug Discov Today. 2020 Mar;25(3):535-51. doi: 10.1016/j.drudis.2020.01.007. Epub 2020 Jan 21.
13. Fan L, Zang L, Liu X, et al. Outcomes of mechanical thrombectomy with pre-intravenous thrombolysis: a systematic review and meta-analysis. J Neurol. 2021 Jul;268(7):2420-8. doi: 10.1007/s00415-020-09778-4. Epub 2020 Mar 5.
14. Douarinou M, Gory B, Consoli A, et al; ETIS Investigators. Impact of Strategy on Clinical Outcome in Large Vessel Occlusion Stroke Successfully Reperfused: ETIS Registry Results. Stroke. 2022 Jan;53(1):e1-e4. doi: 10.1161/STROKEAHA.121.034422. Epub 2021 Nov 3.
15. Alberts MJ, Latchaw RE, Jagoda A, et al; Brain Attack Coalition. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke. 2011 Sep;42(9):2651-65. doi: 10.1161/STROKEAHA.111.615336. Epub 2011 Aug 25.
16. Bhaskar S, Stanwell P, Cordato D, et al. Reperfusion therapy in acute ischemic stroke: dawn of a new era? BMC Neurol. 2018 Jan 16;18(1):8. doi: 10.1186/s12883-017-1007-y
17. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008 Apr;39(4):1205-12. doi: 10.1161/STROKEAHA.107.497115. Epub 2008 Feb 28.
18. Berkhemer OA, Fransen PS, Beumer D, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. doi: 10.1056/NEJMoa1411587
19. Jovin TG, Chamorro A, Cobo E, et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-306. doi: 10.1056/NEJMoa1503780
Review
For citations:
Volchenkova TV, Kotov SV, Isakova EV, Sutormin MV, Patrin EV, Gegenava BB, Martynovich MN, Rudakova IG, Smetana LV, Borisova VA, Belkina SV. The use of thromboaspiration and combined treatment in patients with ischemic stroke in real-life clinical practice. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(2):41-46. (In Russ.) https://doi.org/10.14412/2074-2711-2024-2-41-46
Views:
386
Email this article 